Crossmark

Serum proteins and faecal microbiota as potential biomarkers in newly diagnosed, treatment-naïve inflammatory bowel disease and irritable bowel syndrome patients

Crossref DOI link: https://doi.org/10.1007/s00109-025-02558-5

Published Online: 2025-06-07

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matijašić, Mario

Barešić, Anja https://orcid.org/0000-0003-1303-3031
Čipčić Paljetak, Hana https://orcid.org/0000-0002-8837-3156
Perić, Mihaela

Panek, Marina

Kunović, Ana

Ljubas Kelečić, Dina

Vranešić Bender, Darija

Grubelić Ravić, Katja

Rogić, Dunja

Antolic, Margareta

Horvat, Ivana

Kraljević, Ivana

Banić, Marko

Krznarić, Željko

Verbanac, Donatella
Funding

Funding for this research was provided by:

Hrvatska Zaklada za Znanost (IP-11-2013-5467, DR-6-2014)

European Regional Development Fund (GA KK.01.1.1.01.0008)
License Information

Text and Data Mining valid from 2025-06-07

Version of Record valid from 2025-06-07
More Information

Article History

Received: 6 September 2024

Revised: 21 May 2025

Accepted: 26 May 2025

First Online: 7 June 2025

Declarations

:

: The study was approved by the competent institutional ethics committees (380–59-10106–14-55/149, 641–01/14–02/01; 02/21/JG, 8.1.-14/45–2) and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below